Short answer
SHOULDER INNOVATIONS, INC. (SI) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $17M (down 18.8% year over year) with net income of −$10M.
Q2 2026 key financials · XBRL
- Revenue
- $17M
- −18.8% YoY · +2.8% QoQ
- Net income
- −$10M
- +57.4% YoY · −21.2% QoQ
- Operating margin
- -58.4%
- Gross margin
- 78.3%
- EPS (diluted)
- −$0.49
- +99.8% YoY · −19.5% QoQ
Source: XBRL data from the SHOULDER INNOVATIONS, INC. (SI) Q2 2026 10-Q on SEC EDGAR. USD.
SHOULDER INNOVATIONS, INC. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q2 revenue $17.175M, up 56.0% YoY from $11.013M
- Gross margin 78.3% vs 76.2% YoY
- Implant systems sold 2,238 vs 1,503 YoY
- Net loss $10.153M vs $19.196M; Adjusted EBITDA loss $8.023M vs $18.073M
- R&D investment rose 141.2% to $3.391M, including robotics partnership costs
Risk Factors
- No material changes stated; 2025 Annual Report risk factors remain applicable
- IPO proceeds $64,212 thousand invested primarily in savings and money market accounts
- New debt exposure from June 26, 2026 Loan and Security Agreement with Stifel Bank
- Insider-sale risk: CEO adopted Rule 10b5-1 plan for up to 100,000 shares
- Potential dilution or selling pressure from CEO share sales between September 11, 2026 and June 12, 2027
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SHOULDER INNOVATIONS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.